Showing results (131-140 of 193) with videos related to
Sort By:
Pageof 20
Frontiers in Medicine|August 1, 2020
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Gabriella d'Ettorre, Giancarlo Ceccarelli, Massimiliano Marazzato, et al.Internal and Emergency Medicine|October 12, 2021
PaO2/FiO2 ratio forecasts COVID-19 patients' outcome regardless of age: a cross-sectional, monocentric studyGaia Sinatti, Silvano Junior Santini, Giovanni Tarantino, et al.Virus Research|January 8, 2021
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)Carolina Scagnolari, Alessandra Pierangeli, Federica Frasca, et al.Frontiers in Immunology|March 29, 2021
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 PneumoniaMaria Antonella Zingaropoli, Parni Nijhawan, Anna Carraro, et al.Plos One|August 4, 2016
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV ReactivationMarco Iannetta, Maria Antonella Zingaropoli, Anna Bellizzi, et al.American Journal of Hematology|June 22, 2012
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapyMichele Bibas, Maria Paola Trotta, Alessandro Cozzi-Lepri, et al.Vaccines|October 27, 2022
Evaluation of Immunogenicity to Three Doses of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Lung Transplant PatientsMariasilvia Guardiani, Maria Antonella Zingaropoli, Francesco Cogliati Dezza, et al.Internal and Emergency Medicine|July 4, 2021
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortalityFrancesco Violi, Giancarlo Ceccarelli, Roberto Cangemi, et al.Journal of Medical Virology|April 29, 2021
Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patientsLetizia Santinelli, Gabriella De Girolamo, Cristian Borrazzo, et al.Immunology|June 16, 2026
Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-InfectionMariasilvia Guardiani, Eeva Tortellini, Anna Carraro, et al.Pageof 20